Chapter title |
Marker utility for combination therapy.
|
---|---|
Chapter number | 7 |
Book title |
Molecular Diagnostics for Melanoma
|
Published in |
Methods in molecular biology, January 2014
|
DOI | 10.1007/978-1-62703-727-3_7 |
Pubmed ID | |
Book ISBNs |
978-1-62703-726-6, 978-1-62703-727-3
|
Authors |
Ester Simeone, Antonio M Grimaldi, Paolo A Ascierto, Antonio M. Grimaldi, Paolo A. Ascierto, Simeone, Ester, Grimaldi, Antonio M., Ascierto, Paolo A. |
Abstract |
Melanoma is a heterogeneous disease for which monotherapies are likely to fail in the majority of patients due to genomic variations between individuals. Novel treatments, such as vemurafenib and ipilimumab, offer clinical promise in metastatic melanoma and the increased potential for combined therapeutic strategies, necessary given the differences in response between patients. Together with these new approaches, the development of clinically relevant biomarkers that predict treatment outcomes are required to ensure these new therapies are targeted at those patients most likely to benefit. Here we review the utility of some potential biomarkers of treatment response in patients with metastatic melanoma. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 10% |
Unknown | 9 | 90% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 2 | 20% |
Researcher | 2 | 20% |
Student > Bachelor | 1 | 10% |
Student > Master | 1 | 10% |
Professor | 1 | 10% |
Other | 2 | 20% |
Unknown | 1 | 10% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 3 | 30% |
Medicine and Dentistry | 3 | 30% |
Biochemistry, Genetics and Molecular Biology | 1 | 10% |
Social Sciences | 1 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 10% |
Other | 0 | 0% |
Unknown | 1 | 10% |